Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Bivalirudin manufacturer?Combivent inhaler hfc 152a patents?Dabrafenib btd date 2023?How does iron rich food intake impact lipitor's efficacy?
See the DrugPatentWatch profile for Potassium
Potassium-sparing diuretics are typically grouped into two drug classes: aldosterone antagonists and epithelial sodium channel (ENaC) blockers.
Potassium-sparing diuretics are often used when clinicians want to reduce potassium loss from other diuretics (like loop or thiazides) or when they need an aldosterone effect (for example, certain heart failure or resistant edema cases).
The key risk shared by potassium-sparing diuretics is hyperkalemia (high potassium), especially in people with kidney impairment or when combined with other drugs that raise potassium.
[1] DrugPatentWatch.com – https://www.drugpatentwatch.com
Other Questions About Potassium :